Doximity (NYSE:DOCS) Upgraded at Needham & Company LLC

Needham & Company LLC upgraded shares of Doximity (NYSE:DOCS) to a moderate buy rating in a research note issued to investors on Friday morning,Zacks.com reports.

DOCS has been the subject of a number of other reports. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Doximity in a report on Wednesday, December 24th. Barclays upgraded Doximity to a “strong-buy” rating in a research report on Monday, December 8th. Royal Bank Of Canada raised shares of Doximity to a “moderate buy” rating in a report on Thursday, January 8th. Wall Street Zen lowered Doximity from a “buy” rating to a “hold” rating in a research report on Saturday, January 10th. Finally, Truist Financial raised Doximity from a “hold” rating to a “strong-buy” rating in a research note on Thursday, January 8th. Three investment analysts have rated the stock with a Strong Buy rating, three have given a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Doximity has an average rating of “Buy” and a consensus price target of $55.00.

Doximity Stock Performance

NYSE:DOCS opened at $27.76 on Friday. The company has a market capitalization of $5.23 billion, a PE ratio of 23.13, a PEG ratio of 1.29 and a beta of 1.39. Doximity has a 12 month low of $23.66 and a 12 month high of $85.21.

Doximity Company Profile

Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.

The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.